Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Looks To Ramp Up Branded Generics Via MOU With China's Hisun

This article was originally published in The Pink Sheet Daily

Executive Summary

Somewhat similar to Pfizer's recent agreement with Shanghai Pharmaceuticals Holdings, the deal will focus on manufacturing and broader commercialization of medicines.
Advertisement

Related Content

With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?
With Pfizer As Cornerstone Investor, Will Shanghai Pharmaceutical Be Largest Pharma IPO Ever?
Pfizer Weighs Options For Future Of Established Products Business Unit As Revenues Show Strong Trends: Emerging Markets Earnings Roundup (Part 3)
Outsourcing Your Way Into Trouble: Pfizer Issues Recall After Indian Aurobindo Mislabels Bottles
Will Innovation Replace Branded Generics As Dominant Strategy For Big Pharma In Emerging Markets? (Part 2 of 2)
Expansion Into China's Lower-tier Cities Could Be Growth Driver For Big Pharma
How Much Risk Should Big Pharma Accept To Close Deals In China? (Part 2 of 2)
Chinese API Manufacturer Expands International Presence, Provides Funding For U.S. Startup
Lilly And China's Hisun Complete Technology Transfer For Antibiotic Capreomycin For TB

Topics

Advertisement
UsernamePublicRestriction

Register

PS072387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel